1. Histone H3K27 acetylation precedes active transcription during zebrafish zygotic genome activation as revealed by live-cell analysis.
- Author
-
Sato Y, Hilbert L, Oda H, Wan Y, Heddleston JM, Chew TL, Zaburdaev V, Keller P, Lionnet T, Vastenhouw N, and Kimura H
- Subjects
- Acetylation drug effects, Alpha-Amanitin pharmacology, Animals, Cell Nucleus drug effects, Cell Nucleus metabolism, Embryo, Nonmammalian drug effects, Embryo, Nonmammalian metabolism, Histone Code drug effects, RNA Polymerase II metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Zebrafish Proteins genetics, Zebrafish Proteins metabolism, Zygote drug effects, Gene Expression Regulation, Developmental drug effects, Genome, Histones metabolism, Lysine metabolism, Transcription, Genetic drug effects, Zebrafish embryology, Zebrafish genetics, Zygote metabolism
- Abstract
Histone post-translational modifications are key gene expression regulators, but their rapid dynamics during development remain difficult to capture. We applied a Fab-based live endogenous modification labeling technique to monitor the changes in histone modification levels during zygotic genome activation (ZGA) in living zebrafish embryos. Among various histone modifications, H3 Lys27 acetylation (H3K27ac) exhibited most drastic changes, accumulating in two nuclear foci in the 64- to 1k-cell-stage embryos. The elongating form of RNA polymerase II, which is phosphorylated at Ser2 in heptad repeats within the C-terminal domain (RNAP2 Ser2ph), and miR-430 transcripts were also concentrated in foci closely associated with H3K27ac. When treated with α-amanitin to inhibit transcription or JQ-1 to inhibit binding of acetyl-reader proteins, H3K27ac foci still appeared but RNAP2 Ser2ph and miR-430 morpholino were not concentrated in foci, suggesting that H3K27ac precedes active transcription during ZGA. We anticipate that the method presented here could be applied to a variety of developmental processes in any model and non-model organisms., Competing Interests: Competing interestsThe authors declare no competing or financial interests., (© 2019. Published by The Company of Biologists Ltd.)
- Published
- 2019
- Full Text
- View/download PDF